Insights
Resources & News
The Global Medtech Industry: Visions in Times of Change
The healthcare environment has been transforming faster during the last couple of years. New approaches for managing, financing and competing in healthcare are pushing all players in the sector to constantly question the relevance of their formula for past success. As...
Valuable collection: What are the prospects for grouping complementary services around a product?
In the PME article, ‘If the Shoe Fits’, four emerging pharmaceutical market strategies were identified, based on uniqueness of positioning and type of competition (www. pmlive.com/ shoefits). This next article in the series concentrates on the bottom right quadrant of...
Contract research – Deriving strategic value from emerging markets
Global pharmaceutical companies are re-looking at their R&D processes in order to leverage the opportunity presented by emerging economies, such as India, in contract research. Besides offering the opportunity to save costs tactically in the short term, this is...
Contract Research – Deriving Strategic Value from Emerging Markets
Globally pharmaceutical companies are under immense pressure, with existing lobally pharmaceutical business models under threat. The growth is expected to taper off in the US and other developed countries, while emerging economies are expected to drive a large part of...
Potential to grow: A true understanding of the challenges of niche markets is needed for companies to achieve worthwile returns
For a long time, the pharmaceutical industry was not required to prove superior outcomes to generate large surpluses: companies were paid above the amount required to sustain the economic viability of their product portfolio. Today, severe pressure on healthcare...
Introduction of SwissDRG – upheavals in hospital purchasing require… …new strategies for medical technology providers
Thanks to its international experience, the Swiss medical technology sector is well aware of the latest developments in the healthcare market, especially as smaller companies also tend to work the European markets bordering Switzerland intensively and directly. In the...
If the shoe fits: Pharma needs to put its best foot forward and use the range of tactical responses at its disposal to meet payers’ demands
Despite what we are asked to believe, pharmaceutical marketers used to have it easy. Marketing predominantly to doctors, companies positioned their patent protected drug against competitive products, seeking any meaningful differentiation to drive market share (or...
SwissDRG – opportunities and risks for Swiss hospitals
The SwissDRG remuneration system is intended to take account of the varying degrees of severity of individual diagnoses and procedures. However, the remuneration system does not take into account the respective cost structures and expenses of the hospital for a...
How can the Swiss healthcare system hold its own in an increasingly international environment? Competitive abroad?
The trends of recent years show that the healthcare system is becoming increasingly international. The Swiss hospital sector is faced with facts such as rising healthcare costs, quality controls and patients who seek treatment abroad at low cost. In order to remain...
Insights
Weekly Free Business Resources
If you want to receive weekly business resources and news, please subscribe to our Insights blog.
Almasan AG
The right support for the pharma/ biotech, medtech/ diagnostics, life sciences and healthcare sectors at the right time in the right way: Advisory, Interim Management and Contracting/ Outsourcing.